Abstract：Objective: To explore the levels of serum interleukin-10 (IL-10) and CXC chemokine ligand 16 (CXCL16) in patients with acute coronary syndrome (ACS) and its clinical significance. Methods: A total of 150 patients with ACS admitted to our hospital from June 2018 to June 2019 were selected as study objects (ACS group), who were divided into acute myocardial infarction group (AMI group, n=79) and unstable angina pectoris group (UAP group, n=71) according to the disease type. Also, the patients were divided into mild lesion group (n=65), moderate lesion group (n=52) and severe group (n=33) according to Gensini score. And the patients were divided into single vessel lesion group (n=60), double vessel lesion group (n=58) and triple vessel lesion group (n=32) according to the number of coronary artery lesions. At the same time, 60 patients with stable angina pectoris (SAP group) and 60 healthy volunteers (control group) were randomly selected as controls. The serum IL-10 and CXCL16 levels were detected by enzyme-linked immunosorbent assay. Results: The levels of IL-10 and CXCL16 in ACS group were higher than those in SAP group and control group (P<0.05). The level of IL-10 and CXCL16 in AMI group were higher than those in UAP group (t=9.186, 6.643; P<0.05). With the severity and number of coronary lesions in ACS group, the IL-10 and CXCL16 increased (P<0.05). The serum IL-10 in ACS group was positively associated with the Gensini scores and the number of coronary lesions (r=0.692, 0.702; P<0.05), and the CXCL16 was positively associated with the Gensini scores and the number of coronary lesions (r=0.637, 0.645; P<0.05). The ROC curve analysis showed that IL-10 and CXCL16 have differential diagnostic value for AMI and UAP, and the combined detection of both IL-10 and CXCL16 have a higher differential diagnostic value. The AUC was 0.860 (95%CI: 0.835~0.907), the sensitivity and specificity were 89.67% and 82.39%, and the accuracy was 86.34%. Conclusion: The up-regulation of serum IL-10 and CXCL16 are involved in the pathogenesis of ACS, which are closely related to the Gensini score of coronary lesions and the number of coronary lesions. Early detection of both IL-10 and CXCL16 can be used as important biochemical indexes for clinical differential diagnosis of ACS and assessment of the severity of coronary lesions.
马伟利, 蔡颖, 宝凤梅, 张凤梅, 张莉莉. 急性冠脉综合征患者血清中白细胞介素-10 CXC趋化因子16水平变化及其意义[J]. 河北医学, 2021, 27(2): 254-259.
MA Weili, CAI Ying, BAO Fengmei, et al. Levels of Serum IL-10, CXCL16 in Patients with Acute Coronary Syndrome and Its Clinical Significance. HeBei Med, 2021, 27(2): 254-259.
[1] Chapman AR,Sandeman D,Ferry AV,et al.Risk stratification using high-sensitivity cardiac troponin T in patients with suspected acute coronary syndrome[J].Am Coll Cardiol,2020,75(8):985~987. [2] Gach O,El HZ,Lancellotti P. Acute coronary syndrome[J]. Rev Med Liege,2018,73(5-6):243~250. [3] 许涵,翟春丽,李冰冰.冠心病患者促炎因子IL-1β和抑炎因子IL-10全身与病变局部水平的关系[J].心肺血管病杂志,2018,37(11):968~971. [4] Ajmera V,Huang H,Dao D,et al.Host genetic Variant in CXCL16 May be associated with hepatitis B virus-related acute liver failure[J].Cell Mol Gastroenterol Hepatol,2019,7(2):477~479. [5] O'Connor RE,Brady W,Brooks SC,et al.Part 10:acute coronary syndromes 2010 american heart association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care[J].Circulation,2010,122(188 suppl 3):S787. [6] 刘江萍,木胡牙提.急性冠脉综合征流行病学及危险因素的研究进展[J].国际心血管病杂志,2019,46(1):1~3,7. [7] 伏玲,余学春,董静武.血清DcR3、IL-10和IFN-γ联合检测在急性胰腺炎患者严重程度评估中的价值[J].热带医学杂志,2019,19(12):1539~1542. [8] 梁粤.肺炎支原体肺炎患儿外周血IL-10/IL-17表达与肺功能变化的相关性研究[J].临床儿科杂志,2015,33(8):686~689. [9] Sternby H,Hartman H,Thorlacius H,et al.IL-1β,IL-6,IL-8 and IL-10 are important chronological biomarkers in the inflammatory development of acute pancreatitis[J].Pancreatology,2018,18(4):100~106. [10] 陈美凤,魏芳晶.CXCL16及其受体与冠状动脉粥样硬化的关系[J].心脑血管病防治,2019,19(1):84~86.
2021, Vol. 27 
冀公网安备13080202000677号